The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 151 results:
Author Title Type [ Year(Asc)]
Filters: Author is Mikhailidis, Dimitri P  [Clear All Filters]
2014
Kargiotis, K., Katsiki N., Athyros V. G., Giouleme O., Patsiaoura K., Katsiki E., et al. (2014).  Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report.. Curr Vasc Pharmacol. 12(3), 505-11.
Koumaras, C., Tziomalos K., Stavrinou E., Katsiki N., Athyros V. G., Mikhailidis D. P., et al. (2014).  Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.. J Am Soc Hypertens. 8(2), 74-82.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Metabolic syndrome and non-cardiac vascular diseases: an update from human studies.. Curr Pharm Des. 20(31), 4944-52.
Athyros, V. G., Tziomalos K., Katsiki N., & Mikhailidis D. P. (2014).  Novel data on the pathogenesis of atherosclerosis, treatment targets, and new therapeutic interventions in lipid-related cardiovascular risk factors.. Curr Pharm Des. 20(40), 6215-9.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Peripheral artery disease in patients with type 2 diabetes.. J Diabetes Complications. 28(6), 912.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Reaching hypertriglyceridemia goals.. Curr Med Res Opin. 30(3), 391-3.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  The role of statins in the treatment of type 2 diabetes mellitus: an update.. Curr Pharm Des. 20(22), 3665-74.
Katsiki, N., Athyros V. G., Karagiannis A., Wierzbicki A. S., & Mikhailidis D. P. (2014).  Should we expand the concept of coronary heart disease equivalents?. Curr Opin Cardiol. 29(4), 389-95.
Anagnostis, P., Karras S. N., Athyros V. G., Mikhailidis D. P., & Karagiannis A. (2014).  Subclinical Cushing's syndrome and cardiovascular disease.. Lancet Diabetes Endocrinol. 2(5), 361.
Athyros, V. G., & Mikhailidis D. P. (2014).  Therapy: Caloric and fat intake in statin users.. Nat Rev Endocrinol. 10(8), 450-1.
Athyros, V. G., & Mikhailidis D. P. (2014).  Uric acid, chronic kidney disease and type 2 diabetes: a cluster of vascular risk factors.. J Diabetes Complications. 28(2), 122-3.
2013
Anagnostis, P., Katsiki N., Adamidou F., Athyros V. G., Karagiannis A., Kita M., et al. (2013).  11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?. Metabolism. 62(1), 21-33.
Mikhailidis, D. P., Katsiki N., Athyros V. G., & Karagiannis A. (2013).  Alcohol consumption and the heart.. Int J Cardiol. 168(4), 4319.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".. Dig Liver Dis. 45(1), 82-3.
Athyros, V. G., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2013).  Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review.. Curr Med Res Opin. 29(10), 1263-74.
Kostapanos, M. S., Athyros V. G., Mikhailidis D. P., & Elisaf M. S. (2013).  Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity.. J Clin Lipidol. 7(1), 88.
Tziomalos, K., Athyros V. G., Mikhailidis D. P., & Karagiannis A. (2013).  Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.. Curr Pharm Des. 19(21), 3766-72.
Athyros, V. G., Tziomalos K., Katsiki N., Gossios T. D., Giouleme O., Anagnostis P., et al. (2013).  The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.. Curr Vasc Pharmacol. 11(5), 779-84.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Statins and nonalcoholic fatty liver disease: a bright future?. Expert Opin Investig Drugs. 22(9), 1089-93.
2012
Athyros, V. G., Gossios T. D., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2012).  The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.. Arch Med Sci. 8(1), 6-10.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2012).  Editorial: should chronic kidney disease be considered as a coronary heart disease equivalent?. Curr Vasc Pharmacol. 10(3), 374-7.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.. J Clin Lipidol. 6(1), 93.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study.. Clin Appl Thromb Hemost. 18(1), 113-4.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Lipid lowering agents and the endothelium: an update after 4 years.. Curr Vasc Pharmacol. 10(1), 33-41.
Athyros, V. G., Elisaf M. S., Alexandrides T., Achimastos A., Ganotakis E., Bilianou E., et al. (2012).  Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.. Angiology. 63(5), 358-66.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.